The olfactory bulbectomised rat as a model of depression

被引:551
作者
Song, C
Leonard, BE
机构
[1] Canada Natl Inst Nutrisci & Hlth, Charlottetown, PE C1A 5TI, Canada
[2] Univ Prince Edward Isl, Dept Biomed Sci, AVC, Charlottetown, PE, Canada
[3] Natl Univ Ireland Univ Coll Galway, Galway, Ireland
[4] Univ Maastricht, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
关键词
olfactory bulbectomy; limbic system; depression; behavior; immune changes; neurotransmitter changes; antidepressants;
D O I
10.1016/j.neubiorev.2005.03.010
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Bilateral olfactory bulbectomy results in changes in behavior, and in the endocrine, immune and neurotransmitter systems, that simulates many of those seen in patients with major depression. The olfactory system in the rat forms a part of the limbic region in which the amygdala and hippocampus contribute to the emotional and memory components of behavior. However, the loss of olfaction alone, which results from bulbectomy, is not the major factor that contributes to the behavioral abnormalities as peripherally induced anosmia does not cause the same behavioral changes. Thus it would appear that bulbectomy causes a major dysfunction of the cortical-hippocampal-amygdala circuit that underlies the behavioral and other changes. These neuroanatomical areas also seem to be dysfunctional in the patient with major depression. Chronic, but not acute, administration of antidepressants largely corrects most the behavioral, endocrine, immune and neurotransmitter changes that occur following bulbectomy. Thus the olfactory bulbectomized rat is not only a model for detecting antidepressant activity but also one for exploring the inter-relationships between these systems that are also dysfunctional in patients with major depression. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:627 / 647
页数:21
相关论文
共 240 条
[1]  
ALKHATIB IMH, 1988, ARCH INT PHARMACOD T, V296, P282
[2]   Cytokines, stress and depressive illness: brain-immune interactions [J].
Anisman, H ;
Merali, Z .
ANNALS OF MEDICINE, 2003, 35 (01) :2-11
[3]   Further evidence for the depressive effects of cytokines: Anhedonia and neurochemical changes [J].
Anisman, H ;
Kokkinidis, L ;
Merali, Z .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (05) :544-556
[4]   Histamine and prostaglandin interaction in the central regulation of ACTH secretion [J].
Anthonisen, M ;
Knigge, U ;
Kjaer, A ;
Warberg, J .
NEUROENDOCRINOLOGY, 1997, 66 (02) :68-74
[5]   THE STATE OF LEUKOCYTE ADHESIVENESS - AGGREGATION IN THE PERIPHERAL-BLOOD - A NEW AND INDEPENDENT MARKER OF MENTAL STRESS [J].
ARBER, N ;
BERLINER, S ;
TAMIR, A ;
LIBERMAN, E ;
SEGAL, G ;
PINKHAS, J ;
ARONSON, M .
STRESS MEDICINE, 1991, 7 (02) :75-78
[6]   OLFACTORY BULBECTOMY ALTERS ALPHA-1 ACID GLYCOPROTEIN LEVELS IN RAT PLASMA [J].
ARNOLD, FJ ;
MEYERSON, LR .
BRAIN RESEARCH BULLETIN, 1990, 25 (02) :259-262
[7]   NEUROMODULATION OF THE PHAGOCYTIC RESPONSE [J].
BACIU, I ;
MARINA, C ;
DEREVENCO, P ;
OLTEANU, A ;
PAVEL, T .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1990, 51 (3-4) :345-347
[8]   EVALUATION OF IMMUNE PARAMETERS IN DEPRESSED-PATIENTS [J].
BAUER, ME ;
GAUER, GJ ;
LUZ, C ;
SILVEIRA, RO ;
NARDI, NB ;
VONMUHLEN, CA .
LIFE SCIENCES, 1995, 57 (07) :665-674
[9]   EFFECT OF SOME NEW ANTIDEPRESSANT ON LEARNED HELPLESSNESS AND OLFACTORY BULBECTOMY MODELS OF DEPRESSION [J].
BELLVER, C ;
RUBIO, P ;
TARRIO, P ;
LEONARD, BE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) :2056-2057
[10]   Effects of sigma ligands on NMDA receptor function in the bulbectomy model of depression: a behavioural study in the rat [J].
Bermack, J ;
Lavoie, N ;
Dryver, E ;
Debonnel, G .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2002, 5 (01) :53-62